ARCHIVES

Blumenthal Names Presidential Advisor; Groups Lobby To Limit Her Influence

This article is from The Cancer Letter archive.

Vol. 23 No. 38 | October 3, 1997

Download PDF Visit The Full Archive

Related Articles

NIH Accepting FIRST Applications

May 2, 1986

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

New Announcement For CREG On Radio-Chemotherapy Combines Study New Available

July 28, 1978

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

NCI Budget: How Did NCI Spend Last Year’s Increase? Klausner Lists Activities

November 19, 1999

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011